Global Oral Antidiabetic Drugs Market Survey and Trend Research 2018

May 2018 | 84 pages | ID: G4C3C7C3F09EN
99Strategy

Abstracts

SUMMARY

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Eli Lilly, Merck, Pfizer, Abbott, Sanofi, Sanofi, Sunpharma, Novartis, Novo Nordisk, Boehringer Ingelheim, Takeda Pharmaceuticals, Oramed Pharmaceuticals, Jiangsu Wanbang, Nanjing Xinbai etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Oral Antidiabetic Drugs Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 ORAL ANTIDIABETIC DRUGS MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

PART 4 KEY COMPANIES LIST

4.1 Eli Lilly (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Merck (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Pfizer (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Abbott (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Sanofi (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Sanofi (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Sunpharma (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Novartis (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Novo Nordisk (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Boehringer Ingelheim (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Takeda Pharmaceuticals (Company Overview, Sales Data etc.)
4.12 Oramed Pharmaceuticals (Company Overview, Sales Data etc.)
4.13 Jiangsu Wanbang (Company Overview, Sales Data etc.)
4.14 Nanjing Xinbai (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Oral Antidiabetic Drugs Market 2012-2017, by Type, in USD Million
Table Global Oral Antidiabetic Drugs Market 2012-2017, by Type, in Volume
Table Global Oral Antidiabetic Drugs Market Forecast 2018-2023, by Type, in USD Million
Table Global Oral Antidiabetic Drugs Market Forecast 2018-2023, by Type, in Volume
Table Eli Lilly Overview List
Table Oral Antidiabetic Drugs Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Oral Antidiabetic Drugs Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Oral Antidiabetic Drugs Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbott Overview List
Table Oral Antidiabetic Drugs Business Operation of Abbott (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Oral Antidiabetic Drugs Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Oral Antidiabetic Drugs Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sunpharma Overview List
Table Oral Antidiabetic Drugs Business Operation of Sunpharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Oral Antidiabetic Drugs Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novo Nordisk Overview List
Table Oral Antidiabetic Drugs Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Oral Antidiabetic Drugs Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Pharmaceuticals Overview List
Table Oral Antidiabetic Drugs Business Operation of Takeda Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Oramed Pharmaceuticals Overview List
Table Oral Antidiabetic Drugs Business Operation of Oramed Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Jiangsu Wanbang Overview List
Table Oral Antidiabetic Drugs Business Operation of Jiangsu Wanbang (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Nanjing Xinbai Overview List
Table Oral Antidiabetic Drugs Business Operation of Nanjing Xinbai (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Oral Antidiabetic Drugs Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Oral Antidiabetic Drugs Sales Revenue Share, by Companies, in USD Million
Table Global Oral Antidiabetic Drugs Sales Volume 2012-2017, by Companies, in Volume
Table Global Oral Antidiabetic Drugs Sales Revenue Share, by Companies in 2017, in Volume
Table Oral Antidiabetic Drugs Demand 2012-2017, by Application, in USD Million
Table Oral Antidiabetic Drugs Demand 2012-2017, by Application, in Volume
Table Oral Antidiabetic Drugs Demand Forecast 2018-2023, by Application, in USD Million
Table Oral Antidiabetic Drugs Demand Forecast 2018-2023, by Application, in Volume
Table Global Oral Antidiabetic Drugs Market 2012-2017, by Region, in USD Million
Table Global Oral Antidiabetic Drugs Market 2012-2017, by Region, in Volume
Table Oral Antidiabetic Drugs Market Forecast 2018-2023, by Region, in USD Million
Table Oral Antidiabetic Drugs Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Oral Antidiabetic Drugs Industry Chain Structure
Figure Global Oral Antidiabetic Drugs Market Growth 2012-2017, by Type, in USD Million
Figure Global Oral Antidiabetic Drugs Market Growth 2012-2017, by Type, in Volume
Figure Global Oral Antidiabetic Drugs Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Oral Antidiabetic Drugs Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region